Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595937 | SCV000704139 | uncertain significance | not provided | 2017-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315890 | SCV000739079 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-03-31 | criteria provided, single submitter | clinical testing | The p.V2412A variant (also known as c.7235T>C), located in coding exon 43 of the FLNA gene, results from a T to C substitution at nucleotide position 7235. The valine at codon 2412 is replaced by alanine, an amino acid with similar properties. Based on data from gnomAD, the C allele has an overall frequency of 0.0006% (1/181729 ) total alleles studied, with 1 hemizygote(s) observed. The highest observed frequency was 0.0012% (1/81452) of European (non-Finnish) alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000697313 | SCV000825915 | likely benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323625 | SCV004029208 | uncertain significance | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing |